Micropuncture studies were performed in intact and thyroparathyroidectomized (TPTX) dogs to evaluate the relationship between the absolute level of serum ultrafilterable phosphate concentration (SUFP) and proximal bicarbonate reabsorption. In both groups of animals, a reverse linear relationship was noted between the serum phosphate level and the tubular fluid bicarbonate concentration (TFHCO3). For the intact dogs, TFHCO3 = 32.27 SUFp ± 2.17, r = 0.715, p = 0.02, and for the TPTX dogs, TFHCO3 = 35.68 – 2.39 SUFP ± 2.26; r = 0.619, p < 0.02. Furthermore, when late-proximal tubular values for absolute bicarbonate reabsorptive rate (Thco3)/100 nl single nephron filtrate were plotted against SUFp, a direct relationship was found for both groups; intact dogs: THCO3 = 205 SUFp – 169 ± 136, r = 0.707, p < 0.05; TPTX dogs: THCO3 = 224 SUFp – 882 ± 221, r = 0.625, p < 0.01. Variations in plasma bicarbonate concentration or PCO2 did not contribute to the relationship between SUFP and bicarbonate reabsorption. The data suggest that extracellular fluid phosphate concentration is an important modulator of proximal bicarbonate transport, independent of the action of parathyroid hormone. a number of investigators have documented the fact that alterations in phosphate excretion are accompanied by parallel changes in bicarbonate transport both in the experimental animal [2,3] and in man [4–6]. A characteristic effect of the administration of parathyroid hormone (PTH) is a substantial phosphaturia

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.